Company: AIBT
Filing Date: 2025-05-20
Form Type: 10-Q
Source: 0001096906-25-000861
Chunk: 2

Company: AIBOTICS, INC.
Filing Date: 2025-05-20
Form: 10-Q
Item: Item 1
Chunk 2
---
ITEM 1. FINANCIAL STATEMENTS

AIBIOTICS THERAPIES, INC

CONDENSED CONSOLIDATED BALANCE SHEETS

AS OF MARCH 31, 2025 (UNAUDITED) AND DECEMBER 31, 2024

March 31,

December 31,

2025

2024

(unaudited)

ASSETS

CURRENT ASSETS:

Cash
 
$
156,737

$
185,097

Total Current Assets

156,737

185,097

NON-CURRENT ASSETS: 

Property and equipment, net

-

-

Intangible assets, net

1,107,664

1,271,898

TOTAL ASSETS
 
$
1,264,401

$
1,456,995

LIABILITIES AND STOCKHOLDERS’ DEFICIT

CURRENT LIABILITIES:

Accounts payable and accrued expenses
 
$
443,017

$
283,341

Accrued interest

461,755

399,822

Accrued expenses – related party

936,000

864,000

Convertible note payable, net of debt discount

1,100,000

1,100,000

Notes payable – related party

165,000

165,000

Shares to be issued

1,995,600

2,039,600

TOTAL LIABILITIES

5,101,372

4,851,763

Commitments and contingencies (Note 9 – Commitments and Contingencies)

-

-

MEZZANINE EQUITY

Series B Preferred stock, $0.001 par value; 1,500,000 shares authorized at March 31, 2025 and December 31, 2024; 0 shares issued and outstanding as of March 31, 2025 and December 31, 2024; liquidation preference of $0 as of March 31, 2025 and December 31, 2024

200

200

STOCKHOLDERS’ DEFICIT

Preferred stock, 5,000,000 shares authorized:

Series A Preferred Stock, $0.001 par value, 1 and 0 shares authorized at March 31, 2025 and December 31, 2024, respectively; 1 and 0 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively

-

-

Common stock, $0.001 par